Clinical studiesA meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseasesUne méta-analyse de l’utilisation des antibiotiques en prévention secondaire des maladies cardiovasculaires
References (35)
- et al.
Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae
Microb Pathog
(1996) - et al.
Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses
Lancet
(1999) - et al.
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: Winter infections and death from cardiovascular disease
Lancet
(1994) - et al.
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
Lancet
(1998) - et al.
Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): A randomised, double-blind, placebo-controlled trial
Lancet
(2001) - et al.
Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: A randomised controlled trial
Lancet
(2003) Chlamydia pneumoniae and coronary artery disease: The antibiotic trials
Mayo Clin Proc
(2003)- et al.
Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis
Am Heart J
(1999) Antibiotics in the prevention of heart attacks
Lancet
(2005)- et al.
Heart disease and stroke statistics – 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation
(2006)
The Atlas of Heart Diseases and Stroke
(2006)
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease
JAMA
(2002)
Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and metaanalysis
BMJ
(2000)
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
Circulation
(1998)
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma
J Infect Dis
(2000)
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
Circulation
(1997)
Cited by (0)
Copyright © 2008 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.